Precipitating Mechanisms of Falls in Preclinical Alzheimer's Disease

被引:2
|
作者
Keleman, Audrey A. [1 ]
Nicosia, Jessica y [2 ]
Bollinger, Rebecca M. [1 ]
Wisch, Julie K. [2 ]
Hassenstab, Jason [2 ,3 ]
Morris, John C. [2 ,5 ]
Ances, Beau M. [2 ,4 ,5 ]
Balota, David A. [3 ]
Stark, Susan L. [1 ,2 ]
机构
[1] Washington Univ St Louis, Program Occupat Therapy, St Louis, MO USA
[2] Washington Univ St Louis, Dept Neurol, St Louis, MO USA
[3] Washington Univ St Louis, Dept Psychol, St Louis, MO USA
[4] Washington Univ St Louis, Dept Radiol, St Louis, MO USA
[5] Washington Univ St Louis, Hope Ctr Neurol Disorders, St Louis, MO USA
基金
美国国家卫生研究院;
关键词
Alzheimer's disease; cognition; falls; functional mobility; DWELLING OLDER-PEOPLE; RISK-FACTORS; DATA SET; GAIT SPEED; PERFORMANCE; VALIDATION; VERSION; HEALTH; TAU; PREDICTOR;
D O I
10.3233/ADR-230002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Individuals with Alzheimer's disease (AD) are more than twice as likely to incur a serious fall as the general population of older adults. Although AD is commonly associated with cognitive changes, impairments in other clinical measures such as strength or functional mobility (i.e., gait and balance) may precede symptomatic cognitive impairment in preclinical AD and lead to increased fall risk. Objective: To examine mechanisms (i.e., functional mobility, cognition, AD biomarkers) associated with increased falls in cognitively normal older adults. Methods: This 1-year study was part of an ongoing longitudinal cohort study. We examined the relationships among falls, clinical measures of functional mobility and cognition, and neuroimaging AD biomarkers in cognitively normal older adults. We also investigated which domain(s) best predicted fall propensity and severity through multiple regression models. Results: A total of 182 older adults were included (mean age 75 years, 53% female). A total of 227 falls were reported over the year; falls per person ranged from 0-16 with a median of 1. Measures of functional mobility were the best predictors of fall propensity and severity. Cognition and AD biomarkers were associated with each other but not with the fall outcome measures. Conclusion: These results suggest that, although subtle changes in cognition may be more closely associated with AD neuropathology, functional mobility indicators better predict falls in cognitively normal older adults. This study adds to our understanding of the mechanisms underlying falls in older adults and could lead to the development of targeted fall prevention strategies.
引用
收藏
页码:739 / 750
页数:12
相关论文
共 50 条
  • [31] Cognitive deficits in preclinical Alzheimer's disease
    Small, BJ
    Mobly, JL
    Laukka, EJ
    Jones, S
    Bäckman, L
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 : 29 - 33
  • [32] Neuroimaging to predict preclinical Alzheimer's disease
    Kumari, V
    Mitterschiffthaler, MT
    Sharma, T
    HOSPITAL MEDICINE, 2002, 63 (06): : 341 - 345
  • [33] Pathology of clinical and preclinical Alzheimer’s disease
    Dietmar Rudolf Thal
    Christine von Arnim
    W. Sue T. Griffin
    Haruyasu Yamaguchi
    Robert E. Mrak
    Johannes Attems
    Ajeet Rijal Upadhaya
    European Archives of Psychiatry and Clinical Neuroscience, 2013, 263 : 137 - 145
  • [34] The biomarker signature of preclinical Alzheimer's disease
    Molinuevo, J. L.
    JOURNAL OF NEUROLOGY, 2013, 260 : S9 - S10
  • [35] Trial of Solanezumab in Preclinical Alzheimer's Disease
    Sperling, Reisa A.
    Donohue, Michael C.
    Raman, Rema
    Rafii, Michael S.
    Johnson, Keith
    Masters, Colin L.
    van Dyck, Christopher H.
    Iwatsubo, Takeshi
    Marshall, Gad A.
    Yaari, Roy
    Mancini, Michele
    Holdridge, Karen C.
    Case, Michael
    Sims, John R.
    Aisen, Paul S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12): : 1096 - 1107
  • [36] Preclinical diagnosis of Alzheimer's disease with SPECT
    Johnson, KA
    Jones, KJ
    Becker, JA
    Holman, BL
    Satlin, A
    Albert, MS
    NEUROLOGY, 1997, 48 (03) : 24006 - 24006
  • [37] Falls May be Early Sign of Alzheimer's Disease
    不详
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2011, 26 (06): : 499 - 499
  • [38] Risk of falls in Alzheimer's disease: A prospective study
    Horikawa, E
    Matsui, T
    Arai, H
    Seki, T
    Iwasaki, K
    Sasaki, H
    INTERNAL MEDICINE, 2005, 44 (07) : 717 - 721
  • [39] Overview of Immunotherapy in Alzheimer's Disease (AD) and Mechanisms of IVIG Neuroprotection in Preclinical Models of AD
    Counts, Scott E.
    Lahiri, Debomoy K.
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (07) : 623 - 625
  • [40] Alzheimer's Disease Preclinical Efficacy Database: Improving the Scientific Rigor, Reproducibility, and Predictive Value of Preclinical Research for Alzheimer's Disease
    Chakraborty, Shreaya
    Sharma, Ali
    Martin, Zane
    Yuan, Jean
    Petanceska, Suzana
    Refolo, Lorenzo
    NEUROTHERAPEUTICS, 2022, 19 (04) : 1425 - 1425